Meeting NewsVideo

VIDEO: Early clinical results with Oxervate for neurotrophic keratitis promising

SCOTTSDALE, Ariz. — At Cornea360, Kenneth A. Beckman, MD, discusses his early, promising clinical results with Oxervate (cenegermin-bkbj 0.002% ophthalmic solution, Dompé) for the treatment of neurotrophic keratitis.

SCOTTSDALE, Ariz. — At Cornea360, Kenneth A. Beckman, MD, discusses his early, promising clinical results with Oxervate (cenegermin-bkbj 0.002% ophthalmic solution, Dompé) for the treatment of neurotrophic keratitis.

    See more from Cornea 360